University of Wisconsin–Madison

Engineering Leukocytes Generated from Human iPS Cells to Treat Human Disease

This project could lead to groundbreaking new clinical interventions for patients with neutropenia (an abnormally low level of neutrophils, a common type of white blood cell), antibiotic resistant infections, diabetes, autoimmune disease, cardiovascular disease, and cancer. It relies on the development of cutting-edge techniques for generating neutrophils and macrophages from induced pluripotent stem (iPS) cells […]

Read the full article at: